Perrigo | PRGO - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
AbbVie USD -6.66B 3.39B 2026-03
Abbott USD 52.06B 69M 2026-03
Bayer EUR 28.85B 2.9B 2026-03
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Coherus Biosciences USD 61.01M 26.76M 2025-12
Corcept Therapeutics USD 637.99M 9.82M 2026-03
Dr.Reddys Laboratories INR 378.92B 3.16B 2026-03
Eli Lilly USD 31.2B 4.66B 2026-03
J&J USD 81.19B 358M 2026-03
Merck USD 45.88B 6.73B 2026-03
Nestle CHF 32.81B 3.98B 2025-12
Pacira USD 653.89M 39.22M 2026-03
Perrigo USD 2.5B 436.7M 2026-03
Pfizer USD 90.1B 3.63B 2026-03
Phibro Animal Health USD 361.83M 29.47M 2026-03
Prestige Brands USD 1.89B 58.06M 2026-03
Reckitt Benckiser GBP 6.7B 1.39B 2024-12
Sanofi EUR 72.81B 1.1B 2026-03
Supernus Pharmaceuticals USD 1.08B 15.09M 2026-03
Teva Pharmaceutical Industries USD 8.23B 314M 2026-03
Xeris Pharmaceuticals USD 13.01M 678K 2026-03
Zoetis USD 3.23B 98M 2026-03